| Financial Year |
March 31 2023 |
| Monetary Funds |
555,231,552.07 |
| Held-for-trading Financial Assets |
150,491,722.22 |
| Notes Receivable |
143,354,954.72 |
| Accounts Receivable |
307,076,578.58 |
| Advances to Suppliers |
16,186,893.12 |
| Other Receivables |
15,209,195.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
477,907,833.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,939,472.35 |
| Total Current Assets |
1,703,786,679.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
34,788,547.70 |
| Investment Properties |
106,986,871.31 |
| Fixed Assetes |
1,007,642,342.87 |
| Under-construction Projects |
104,215,287.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
78,167,927.43 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
12,664,487.20 |
| Deferred Income Tax Assets |
39,644,247.35 |
| Other Non-Current Assets |
61,223,219.18 |
| Sub-Total of Non-Current Assets |
1,578,836,284.57 |
| Total Assets |
3,282,622,964.52 |
| Short-Term Loans |
160,178,291.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
495,546,165.44 |
| Accounts Payable |
375,552,984.42 |
| Accounts Received In Advance |
3,032,305.31 |
| Employee Compensation Payable |
27,806,402.78 |
| Taxes Payable |
4,670,589.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
82,078,703.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,505,646.96 |
| Other Current Liabilities |
10,177,851.67 |
| Sub-Total of Current Liabilities |
1,227,108,256.58 |
| Long-term Loans |
61,083,240.81 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,135,269.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
181,497,214.65 |
| Total Liabilities |
1,408,605,471.23 |
| Paid-In Capital(Or Share Stock) |
524,904,562.00 |
| Capital Surplus |
1,494,995,304.92 |
| Surplus Reserve |
144,399,137.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-281,636,878.22 |
| Minority Stockholder's Interest |
5,629,509.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,868,387,984.13 |
| Owner's Equity（Stockholder's Equity） |
1,874,017,493.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,282,622,964.52 |
